Veterinary Medicines

Exidot 250 mg Spot-on solution for Large Dogs

Not authorised
  • Imidacloprid
Download as PDF

Product identification

Medicine name:
Exidot 250 mg Spot-on solution for Large Dogs
Exidot 250 mg Lösung zum Auftropfen für große Hunde
Active substance:
  • Imidacloprid
Target species:
  • Dog
Route of administration:
  • Spot-on use

Product details

Active substance and strength:
  • Imidacloprid
    250.00
    milligram(s)
    /
    1.00
    Pipette
Pharmaceutical form:
  • Spot-on solution
Withdrawal period by route of administration:
  • Spot-on use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AX17
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Germany
Package description:
  • A white pipette composed of a heat-formed shell of a polypropylene/cyclic olefin copolymer/polypropylene layer and apolyethylene/ethylene vinyl alcohol/polyethylene layer.Cardboard Box with 160 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of a polypropylene/cyclic olefin copolymer/polypropylene layer and apolyethylene/ethylene vinyl alcohol/polyethylene layer.Cardboard Box with 150 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of a polypropylene/cyclic olefin copolymer/polypropylene layer and apolyethylene/ethylene vinyl alcohol/polyethylene layer.Cardboard Box with 90 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of a polypropylene/cyclic olefin copolymer/polypropylene layer and apolyethylene/ethylene vinyl alcohol/polyethylene layer.Cardboard Box with 60 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of a polypropylene/cyclic olefin copolymer/polypropylene layer and apolyethylene/ethylene vinyl alcohol/polyethylene layer.Cardboard Box with 30 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of a polypropylene/cyclic olefin copolymer/polypropylene layer and apolyethylene/ethylene vinyl alcohol/polyethylene layer.Cardboard Box with 24 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of a polypropylene/cyclic olefin copolymer/polypropylene layer and apolyethylene/ethylene vinyl alcohol/polyethylene layer.Cardboard Box with 21 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of a polypropylene/cyclic olefin copolymer/polypropylene layer and apolyethylene/ethylene vinyl alcohol/polyethylene layer.Cardboard Box with 20 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of a polypropylene/cyclic olefin copolymer/polypropylene layer and apolyethylene/ethylene vinyl alcohol/polyethylene layer.Cardboard Box with 18 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of a polypropylene/cyclic olefin copolymer/polypropylene layer and apolyethylene/ethylene vinyl alcohol/polyethylene layer.Cardboard Box with 15 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of a polypropylene/cyclic olefin copolymer/polypropylene layer and apolyethylene/ethylene vinyl alcohol/polyethylene layer.Cardboard Box with 12 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of a polypropylene/cyclic olefin copolymer/polypropylene layer and apolyethylene/ethylene vinyl alcohol/polyethylene layer.Cardboard Box with 10 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of a polypropylene/cyclic olefin copolymer/polypropylene layer and apolyethylene/ethylene vinyl alcohol/polyethylene layer.Cardboard Box with 9 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of a polypropylene/cyclic olefin copolymer/polypropylene layer and apolyethylene/ethylene vinyl alcohol/polyethylene layer.Cardboard Box with 8 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of a polypropylene/cyclic olefin copolymer/polypropylene layer and apolyethylene/ethylene vinyl alcohol/polyethylene layer.Cardboard Box with 6 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of a polypropylene/cyclic olefin copolymer/polypropylene layer and apolyethylene/ethylene vinyl alcohol/polyethylene layer.Cardboard Box with 4 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of a polypropylene/cyclic olefin copolymer/polypropylene layer and apolyethylene/ethylene vinyl alcohol/polyethylene layer.Cardboard Box with 3 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of a polypropylene/cyclic olefin copolymer/polypropylene layer and apolyethylene/ethylene vinyl alcohol/polyethylene layer.Cardboard Box with 2 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of a polypropylene/cyclic olefin copolymer/polypropylene layer and apolyethylene/ethylene vinyl alcohol/polyethylene layer.Cardboard Box with 1 pipette in individual foil sachets.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 402545.00.00
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0414/004

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."